Cargando…

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis

AIM: To investigate the impact of medication beliefs, illness perceptions and quality of life on medication adherence in people with decompensated cirrhosis. METHODS: One hundred adults with decompensated cirrhosis completed a structured questionnaire when they attended for routine outpatient hepato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayward, Kelly L, Valery, Patricia C, Martin, Jennifer H, Karmakar, Antara, Patel, Preya J, Horsfall, Leigh U, Tallis, Caroline J, Stuart, Katherine A, Wright, Penny L, Smith, David D, Irvine, Katharine M, Powell, Elizabeth E, Cottrell, W Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677197/ https://www.ncbi.nlm.nih.gov/pubmed/29142479 http://dx.doi.org/10.3748/wjg.v23.i40.7321

Ejemplares similares

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
por: Hayward, Kelly L., et al.
Publicado: (2021)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2020)

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial
por: Hayward, Kelly L., et al.
Publicado: (2017)

Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2022)

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
por: Hayward, Kelly L., et al.
Publicado: (2016)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
por: Ju, Young-Cheol, et al.
Publicado: (2018)

Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation
por: Gadd, Victoria L., et al.
Publicado: (2016)

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
por: Shen, Zi-Xuan, et al.
Publicado: (2022)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
por: Irvine, Katharine M., et al.
Publicado: (2021)

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
por: Johnson, Amy L., et al.
Publicado: (2021)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

Assessment of knowledge, cultural beliefs, and behavior regarding medication safety among residents in Harbin, China
por: Liu, Xuan-Tong, et al.
Publicado: (2023)

A new theory to promote self-management of symptom clusters and healthcare quality in patients with decompensated cirrhosis
por: Liu, Zhen, et al.
Publicado: (2023)

Defining Physiological Decompensation: An Expert Consensus and Retrospective Outcome Validation
por: Mitchell, Oscar J. L., et al.
Publicado: (2022)

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies
por: Hayward, Kelly L, et al.
Publicado: (2020)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Reply
por: Hayward, Kelly L., et al.
Publicado: (2019)

Hospital resource intensity and cirrhosis mortality in United States
por: Mathur, Amit K, et al.
Publicado: (2017)

Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)
por: Valery, Patricia C, et al.
Publicado: (2020)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
por: Zhong, Hao-Jie, et al.
Publicado: (2019)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study
por: Johnson, Amy L, et al.
Publicado: (2021)

Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
por: Choi, Gwang Hyeon, et al.
Publicado: (2022)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
por: Guardigni, Viola, et al.
Publicado: (2017)

Joint engineering‐medical school programs prepare physicians for clinical challenges: An observational study
por: Gathman, Tyler J., et al.
Publicado: (2023)

Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qfqj5d6feahre6i4enlddj035k